GMEX Robotics Corp

Análisis de la acción GMEX Robotics Corp (GMEX)

$1.030

-0.048 (-4.63%)Al cierre

Loading chart…
High
1.100
Open
1.100
VWAP
1.04
Vol
377.85K
Mkt Cap
Low
1.000
Amount
394.22K
EV/EBITDA, TTM
0.00

GMEX Robotics Corporation, formerly Fitell Corporation, is a technology company. The Company is focused on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. The Company is operating at the intersection of consumer health and advanced automation.

AI analysis of GMEX Robotics Corp (GMEX)

sell

GMEX is not a good buy right now. The current price is $1.03, and the stock has seen a staggering year-to-date change of -99.14%. Additionally, the RSI is at 28.175, indicating that the stock is in oversold territory, but this is not a strong enough signal to justify a buy given the overall negative performance and financial metrics.

Métricas de valoración

The current forward P/E ratio for GMEX Robotics Corp (GMEX) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Cronología de eventos

2026-07-28 (ET)

09:30:00

GMEX Robotics Enters Share Purchase Agreement with Alpha Meta AI

2026-07-14 (ET)

09:30:00

GMEX Robotics Signs Letter of Intent for Acquisition

2026-07-06 (ET)

09:00:00

GMEX Robotics Signs LOI to Acquire Equity Interest in California Company

2026-07-01 (ET)

20:00:00

GMEX Robotics Corp Trading Halted, News Pending

2026-06-29 (ET)

19:00:00

Stock Futures Slightly Lower as Investors Await Middle East News

Noticias

GMEX FAQ — answered by Alphio AI

GMEX Robotics Corporation, formerly Fitell Corporation, is a technology company. The Company is focused on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. The Company is operating at the intersection of consumer health and advanced automation. It operates in the Consumer Cyclicals sector.

GMEX is not a good buy right now. The current price is $1.03, and the stock has seen a staggering year-to-date change of -99.14%. Additionally, the RSI is at 28.175, indicating that the stock is in oversold territory, but this is not a strong enough signal to justify a buy given the overall negative performance and financial metrics.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis